The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Dyslipidemia in type 2 diabetes mellitus
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
Mensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081
Bantle (2008) · doi:10.2337/dc08-s061 · Cited by 1,795
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
Kastelein, J. J. P., Akdim, F., Stroes, E. S. G., Zwinderman, A. H., Bots, M. L., Stalenhoef, A. F. H., Visseren, F. L. J., Sijbrands, E. J. G., Trip, M. D., Stein, E. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800742 · Cited by 1,241
Appel, L. J., Sacks, F. M., Carey, V. J., Obarzanek, E., Swain, J. F., Miller, E. R., Conlin, P. R., Erlinger, T. P., Rosner, B. A., Laranjo, N. M., et al. (2005) · JAMA · doi:10.1001/jama.294.19.2455 · Cited by 1,170
Diabetic dyslipidaemia: from basic research to clinical practice*
Taskinen, M.-R. (2003) · Diabetologia · doi:10.1007/s00125-003-1111-y · Cited by 888
McQueen, M. J., Hawken, S., Wang, X., Ounpuu, S., Sniderman, A., Probstfield, J., Steyn, K., Sanderson, J. E., Hasani, M., Volkova, E., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61076-4 · Cited by 864
Diabetes and Decline in Heart Disease Mortality in US Adults
Gu, K. (1999) · JAMA · doi:10.1001/jama.281.14.1291 · Cited by 856
Lipoprotein Management in Patients With Cardiometabolic Risk
Brunzell, J. D., Davidson, M., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., & Witztum, J. L. (2008) · Diabetes Care · doi:10.2337/dc08-9018 · Cited by 707
Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study
Kannel, W. B. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90224-8 · Cited by 665
Almdal, T., Scharling, H., Jensen, J. S., & Vestergaard, H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.13.1422 · Cited by 650
Dyslipidemia Management in Adults With Diabetes
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s68 · Cited by 445
Durrington, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14234-1 · Cited by 307
Safety and Efficacy of Omacor in Severe Hypertriglyceridemia
Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L., & Osmundsen, K. (1997) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679700400511 · Cited by 306
Cannon, C. P., Giugliano, R. P., Blazing, M. A., Harrington, R. A., Peterson, J. L., Sisk, C. M., Strony, J., Musliner, T. A., McCabe, C. H., Veltri, E., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.07.023 · Cited by 299
Borggreve, S. E., De Vries, R., & Dullaart, R. P. F. (2003) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2003.01263.x · Cited by 278
Davidson, M. H., Maki, K. C., Pearson, T. A., Pasternak, R. C., Deedwania, P. C., McKenney, J. M., Fonarow, G. C., Maron, D. J., Ansell, B. J., Clark, L. T., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.04.019 · Cited by 270
Safety and efficacy of Omacor in severe hypertriglyceridemia
Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L., & Osmundsen, K. (1997) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199710000-00011 · Cited by 252
Howard, B. V. (2008) · JAMA · doi:10.1001/jama.299.14.1678 · Cited by 241
Chahil, T. J., & Ginsberg, H. N. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.06.002 · Cited by 233
Adipose tissue and the insulin resistance syndrome
Frayn, K. N. (2001) · Proceedings of the Nutrition Society · doi:10.1079/pns200195 · Cited by 217
Adiels, M., Westerbacka, J., Soro-Paavonen, A., Häkkinen, A. M., Vehkavaara, S., Caslake, M. J., Packard, C., Olofsson, S. O., Yki-Järvinen, H., Taskinen, M. R., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0790-1 · Cited by 198
Cheung, M. C., Zhao, X.-Q., Chait, A., Albers, J. J., & Brown, B. G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0801.095151 · Cited by 190
U.K. Prospective Diabetes Study Group (1997) · Diabetes Care · doi:10.2337/diacare.20.11.1683 · Cited by 179
Sprafka, J. M., Burke, G. L., Folsom, A. R., McGovern, P. G., & Hahn, L. P. (1991) · Diabetes Care · doi:10.2337/diacare.14.7.537 · Cited by 171
Exercise Is Required for Visceral Fat Loss in Postmenopausal Women with Type 2 Diabetes
Giannopoulou, I., Ploutz-Snyder, L. L., Carhart, R., Weinstock, R. S., Fernhall, B., Goulopoulou, S., & Kanaley, J. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1782 · Cited by 159
Cardiovascular Disease in Type 2 Diabetes Mellitus: Current Management Guidelines
Mooradian, A. D. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.33 · Cited by 159
Self-citationAdiponectin Is an Important Determinant of ApoA-I Catabolism
Vergès, B. L., Petit, J., Duvillard, L., Dautin, G., Florentin, E., Galland, F., & Gambert, P. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000219611.50066.bd · Cited by 145
Dietary and Genetic Probes of Atherogenic Dyslipidemia
Krauss, R. M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000186365.73973.f0 · Cited by 124
Dyslipidemia in type 2 diabetes
Krauss, R. M., & Siri, P. W. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.004 · Cited by 120
Transcriptional Control of Apolipoprotein A-I Gene Expression in Diabetes
Mooradian, A. D., Haas, M. J., & Wong, N. C. W. (2004) · Diabetes · doi:10.2337/diabetes.53.3.513 · Cited by 120
Self-citationObesity‐related Changes in High‐density Lipoprotein Metabolism
Mooradian, A. D., Haas, M. J., Wehmeier, K. R., & Wong, N. C. W. (2008) · Obesity · doi:10.1038/oby.2008.202 · Cited by 117
Self-citationZhao, X.-Q., Morse, J. S., Dowdy, A. A., Heise, N., DeAngelis, D., Frohlich, J. J., Chait, A., Albers, J. J., & Brown, B. G. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.10.009 · Cited by 112
Shepherd, J., Betteridge, J. D., Gaal, L. V., & Panel, O. B. O. A. E. C. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x43677 · Cited by 102
Alam, S., Stolinski, M., Pentecost, C., Boroujerdi, M. A., Jones, R. H., Sönksen, P. H., & Umpleby, A. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031036 · Cited by 98
Lichtenstein, A. H. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600019-jlr200 · Cited by 96
Mooradian, A. D., Haas, M. J., & Wong, N. C. W. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0013 · Cited by 91
Self-citationBallantyne, C. M., Davidson, M. H., McKenney, J. M., Keller, L. H., Bajorunas, D. R., & Karas, R. H. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.092 · Cited by 90
Influence of glycemic load on HDL cholesterol in youth1–3
Slyper, A. H., Jurva, J. W., Pleuss, J. A., Hoffmann, R. G., & Gutterman, D. D. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.81.2.376 · Cited by 81
de Vries, R., Perton, F. G., Dallinga‐Thie, G. M., van Roon, A. M., Wolffenbuttel, B. H. R., van Tol, A., & Dullaart, R. P. F. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3554 · Cited by 79
Wilund, K. R., Ferrell, R. E., Phares, D. A., Goldberg, A. P., & Hagberg, J. M. (2002) · Metabolism · doi:10.1053/meta.2002.32730 · Cited by 75
Familial Dyslipidaemias: An Overview of Genetics, Pathophysiology and Management
Hachem, S. B., & Mooradian, A. D. (2006) · Drugs · doi:10.2165/00003495-200666150-00005 · Cited by 74
Self-citationHalverstadt, A., Phares, D. A., Ferrell, R. E., Wilund, K. R., Goldberg, A. P., & Hagberg, J. M. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00284-1 · Cited by 74
Karas, R. H., Kashyap, M. L., Knopp, R. H., Keller, L. H., Bajorunas, D. R., & Davidson, M. H. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200808020-00001 · Cited by 56
Management of Diabetic Dyslipidemia
Solano, M. D. P., & Goldberg, R. B. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.001 · Cited by 53
May, H. T., Anderson, J. L., Pearson, R. R., Jensen, J. R., Horne, B. D., Lavasani, F., Yannicelli, H. D., & Muhlestein, J. B. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.09.095 · Cited by 50
Meksawan, K., Pendergast, D. R., Leddy, J. J., Mason, M., Horvath, P. J., & Awad, A. B. (2004) · Journal of the American College of Nutrition · doi:10.1080/07315724.2004.10719353 · Cited by 50
Dullaart, R. P. F., de Vries, R., Scheek, L. M., Borggreve, S. E., van Tol, A., Dallinga‐Thie, G. M., Ito, M., Nagano, M., Sluiter, W. J., Hattori, H., et al. (2004) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510410005721 · Cited by 49
The Role of Thiazolidinediones in the Treatment of Patients with Type 2 Diabetes Mellitus
Mooradian, A. D., Chehade, J. M., & Thurman, J. E. (2002) · Treatments in Endocrinology · doi:10.2165/00024677-200201010-00002 · Cited by 48
Self-citationSigal, R. J., Kenny, G. P., Boulé, N. G., Wells, G. A., Prud'homme, D., Fortier, M., Reid, R. D., Tulloch, H., Coyle, D., Phillips, P., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-6-200709180-00005 · Cited by 48
Beers, A., Haas, M. J., Wong, N. C. W., & Mooradian, A. D. (2006) · Biochemistry · doi:10.1021/bi0518040 · Cited by 47
Self-citationPharmacologic Treatment of Type 2 Diabetic Dyslipidemia
Moon, Y. S. K., & Kashyap, M. L. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.17.1692.52340 · Cited by 46
Constance, C. M., Westphal, S., Chung, N., Lund, M., Sisk, C. M., Johnson‐Levonas, A. O., Massaad, R., & Allen, C. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00725.x · Cited by 44
van Lennep, H. W. O. R., Liem, A. H., Dunselman, P. H. J. M., Dallinga‐Thie, G. M., Zwinderman, A. H., & Jukema, J. W. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x273273 · Cited by 41
Mooradian, A. D., Albert, S. G., & Haas, M. J. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00636.x · Cited by 38
Self-citationObesity: A rational target for managing diabetes mellitus
Mooradian, A. D. (2001) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(01)80013-7 · Cited by 36
Self-citationHarchaoui, K. E., Akdim, F., Stroes, E. S. G., Trip, M. D., & Kastelein, J. J. P. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200808040-00003 · Cited by 32
Williams, P. T. (2004) · Metabolism · doi:10.1016/j.metabol.2004.01.004 · Cited by 29
Controlling lipid levels in diabetes
Taskinen, M. (2002) · Acta Diabetologica · doi:10.1007/s005920200023 · Cited by 28
Mooradian, A. D., Haas, M. J., & Wadud, K. (2006) · Metabolism · doi:10.1016/j.metabol.2005.08.008 · Cited by 17
Self-citationEvaluation of phospholipid transfer protein as a therapeutic target
Vergeer, M., Dallinga‐Thie, G. M., Dullaart, R. P. F., & van Tol, A. (2008) · Future Lipidology · doi:10.2217/17460875.3.3.327 · Cited by 11
Vergeer, M., & Kastelein, J. J. P. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1190 · Cited by 8
Cited by
Diet–microbiota interactions as moderators of human metabolism
Sonnenburg, J. L., & Bäckhed, F. (2016) · Nature · doi:10.1038/nature18846 · Cited by 2,257
Brown adipose tissue activity controls triglyceride clearance
Bartelt, A., Bruns, O. T., Reimer, R., Hohenberg, H., Ittrich, H., Peldschus, K., Kaul, M. G., Tromsdorf, U. I., Weller, H., Waurisch, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2297 · Cited by 1,608
Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients
Sherwani, S. I., Khan, H. A., Ekhzaimy, A., Masood, A., & Sakharkar, M. K. (2016) · Biomarker Insights · doi:10.4137/bmi.s38440 · Cited by 1,381
Morrison, J., Knoblauch, N., Marcus, J. H., Stephens, M., & He, X. (2020) · Nature Genetics · doi:10.1038/s41588-020-0631-4 · Cited by 591
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Daryabor, G., Atashzar, M. R., Kabelitz, D., Meri, S., & Kalantar, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01582 · Cited by 581
Metadata
- Authors
- Mooradian, A. D.
- Venue
- Nature Reviews Endocrinology
- Published
- 2009-03
- Volume
- 5
- Issue
- 3
- Pages
- 150-159
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2102063342
- Cited by
- 1,042
- References
- 69
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.